Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Avadel Pharmaceuticals PLC. (AVDL) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$77.47M |
|
$0.02M |
|
$-4.12M |
|
$81.58M |
|
$75.53M |
|
$1.94M |
|
$-1.88M |
|
$0.05M |
|
$0.05M |
|
$0.02M |
|
$0.02M |
|
$0.02M |
|
$0.02M |
|
$1.94M |
|
$3.05M |
|
97.10M |
|
101.28M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$172.23M |
|
$0.47M |
|
$27.22M |
|
$199.45M |
|
$62.49M |
|
-- |
|
$38.74M |
|
$101.22M |
|
$98.22M |
|
$81.39M |
|
$98.22M |
|
97.33M |
|
| Cash Flow Statement Financials | |
$26.67M |
|
$-4.37M |
|
$4.18M |
|
$51.37M |
|
$79.81M |
|
$28.44M |
|
$14.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
0.05 |
|
105.31% |
|
2.50% |
|
2.50% |
|
-- |
|
0.07% |
|
0.03% |
|
$26.48M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
-0.17 |
|
1.83 |
|
49.31 |
|
0.02% |
|
0.02% |
|
0.01% |
|
0.02% |
|
$1.01 |
|
$0.26 |
|
$0.26 |
|